This was the stock's second consecutive day of losses.
Investor's Business Daily on MSN10d
Catalyst Pharma Battles To All-Time High After Huge Patent Lawsuit WinAnd Catalyst Pharmaceuticals stock is one of those that seems to be thriving. Catalyst is Thursday's selection for IBD 50 ...
Insider Monkey on MSN10d
Jim Cramer on Catalyst Pharmaceuticals (CPRX): ‘That’s My Kind of Stock!’We recently published a list of Jim Cramer Discussed These 6 Stocks Recently. In this article, we are going to take a look at ...
Renaissance Investment Management, an investment management company, released its Q4 2024 “Small Cap Growth Strategy” investor letter. A copy of the letter can be downloaded here. The Russell 2000 ...
Catalyst Pharmaceuticals Stock Performance Catalyst Pharmaceuticals stock opened at $24.46 on Thursday. The firm has a market cap of $2.97 billion, a price-to-earnings ratio of 20.73, a price-to ...
As predicted by many analysts, economists, and investors, the sweeping tariffs announced by the Trump administration on Wednesday decimated the stock market on Thursday. It had one of its worst ...
A major breakthrough in liquid catalysis is transforming how essential products are made, making the chemical manufacturing ...
Shares of Catalyst Pharmaceuticals Inc. CPRX shed 1.43% to $24.11 Thursday, on what proved to be an all-around grim trading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback